This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: The University of Chicago, University of Illinois. Active years: 2025.
Company Filing History:
1 out of 961 
1 out of 2,420 
Years Active: 2025
Title: Innovations in Cancer Treatment by Inventor Karin Schreiber
Introduction
Karin Schreiber is a prominent inventor based in Chicago, IL, who has made significant contributions to the field of cancer treatment. With a focus on innovative therapies, she has developed groundbreaking methods that aim to improve patient outcomes in oncology. Her work is characterized by a commitment to advancing medical science through her inventive spirit.
Latest Patents
Karin Schreiber holds a patent for a cancer treatment involving 237 CAR-T cell-based therapeutics that recognize the Tn epitope. This patent provides a detailed disclosure of Tn epitope-specific chimeric antigen receptors and single-chain variable fragments (scFvs). It includes both soluble and multimeric scFvs, as well as methods for identifying cancer subjects and sub-populations that are amenable to anti-Tn immunotherapy. The methods outlined in her patent offer promising avenues for treating cancer effectively.
Career Highlights
Throughout her career, Karin has worked with esteemed institutions such as the University of Chicago and the University of Illinois. Her experience in these research environments has allowed her to collaborate with leading experts in the field and contribute to significant advancements in cancer research.
Collaborations
Karin has collaborated with notable colleagues, including Hans Schreiber and David M. Kranz. These partnerships have enriched her research and have been instrumental in the development of her innovative cancer therapies.
Conclusion
Karin Schreiber's contributions to cancer treatment through her innovative patent and collaborative efforts highlight her dedication to improving healthcare outcomes. Her work exemplifies the impact of inventive thinking in the medical field.